纤维囊性乳腺疾病的临床试验
总计380887个结果
-
Washington University School of MedicineNational Cancer Institute (NCI)终止II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌 | HER2 阴性乳腺癌美国
-
National Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的男性乳腺癌 | IV 期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌美国
-
Imperial College Healthcare NHS TrustImperial College London终止
-
Susanne Crocamo完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)主动,不招人II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | 雌激素受体阳性乳腺癌 | 孕激素受体阳性乳腺癌 | 肌肉骨骼并发症美国
-
University of Colorado, Denver主动,不招人
-
University of NebraskaNational Cancer Institute (NCI)终止
-
University of Southern CaliforniaNational Cancer Institute (NCI)完全的
-
National Cancer Institute (NCI)完全的I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | 三阴性乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌 | 健康,无疾病迹象美国
-
Cancer Trials Ireland终止转移性乳腺癌 | HER2阳性乳腺癌 | 局部晚期乳腺癌 | 不可切除的乳腺癌爱尔兰, 西班牙
-
Masaryk UniversityMasaryk Memorial Cancer Institute招聘中
-
University of Chicago招聘中
-
Stanford UniversityNational Institutes of Health (NIH); University of California; Breast Cancer Research Foundation; California Breast Cancer Research Program主动,不招人
-
Providence Health & ServicesBristol-Myers Squibb; Memorial Sloan Kettering Cancer Center主动,不招人
-
University of WashingtonNational Cancer Institute (NCI)撤销
-
University of WashingtonNational Cancer Institute (NCI)完全的IV 期乳腺癌 | 三阴性乳腺癌 | 复发性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
Jonsson Comprehensive Cancer CenterDaiichi Sankyo Co., Ltd.; Translational Research in Oncology-U.S招聘中浸润性乳腺癌 | II期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | 激素受体阳性乳腺癌 | 早期乳腺癌 | III期乳腺癌美国
-
Filipa Lynce, MDMerck Sharp & Dohme LLC; Zentalis Pharmaceuticals尚未招聘乳腺癌 | 三阴性乳腺癌 | 乳腺癌女性 | HER2 阴性乳腺癌 | 激素受体阴性乳腺癌三联美国
-
City of Hope Medical Center终止I期乳腺癌 | 癌症幸存者 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IIIC期乳腺癌美国
-
G1 Therapeutics, Inc.终止乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | 三阴性乳腺肿瘤美国, 保加利亚, 克罗地亚, 斯洛文尼亚, 塞尔维亚, 比利时, 北马其顿, 斯洛伐克
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLC完全的
-
University of California, IrvineNational Cancer Institute (NCI); National Institutes of Health (NIH)完全的乳腺癌 | HER2阳性乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 复发性乳腺癌 | HER2 阴性乳腺癌美国
-
University of Maryland, BaltimoreSyndax Pharmaceuticals终止I期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | 三阴性乳腺癌 | 雌激素受体阴性乳腺癌 | 孕激素受体阴性乳腺癌 | HER2 阴性乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的HER2阳性乳腺癌 | IV 期乳腺癌 | II期乳腺癌 | IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性乳腺癌美国
-
University of WashingtonNational Cancer Institute (NCI)完全的
-
University of WashingtonNational Cancer Institute (NCI)终止
-
The First Affiliated Hospital of Xinxiang Medical...AstraZeneca招聘中
-
NSABP Foundation IncRoyal Marsden NHS Foundation Trust; Pfizer; Institute of Cancer Research, United Kingdom完全的乳腺癌 | 乳腺肿瘤 | 乳腺癌英国, 美国, 加拿大
-
University of WashingtonNational Cancer Institute (NCI)完全的IIIA期乳腺癌 | IIIB期乳腺癌 | IA期乳腺癌 | IB 期乳腺癌 | IIA期乳腺癌 | IIB期乳腺癌 | IIIC期乳腺癌 | 雌激素受体阳性 | HER2/Neu 阴性 | 男性乳腺癌美国
-
Wake Forest University Health Sciences完全的
-
National Taiwan University Hospital招聘中
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger HF; St. Olavs Hospital 和其他合作者完全的
-
MedSIRMacroGenics; Seagen Inc.撤销晚期乳腺癌 | 转移性乳腺癌 | HER2阳性乳腺癌
-
McMaster University完全的
-
Organon and CoInstitute for Applied Economics and Health Research Aps完全的
-
Salah Azaïz Cancer Institute未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.招聘中
-
Northwestern UniversityNational Cancer Institute (NCI)尚未招聘转移性乳腺癌 | 雌激素受体阳性乳腺癌 | HER2/Neu 阴性乳腺癌 | 晚期乳腺癌v美国
-
Kathy MillerGenentech, Inc.招聘中